Skip to content

Clinical study optimizing temperature of disposable warmers for Raynaud's phenomenon

Clinical study to investigate the optimal temperature of disposable warmers for SSc patients with Raynaud's phenomenon

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs052240191
Enrollment
24
Registered
2024-11-21
Start date
2024-12-06
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic sclerosis systemic sclerosis, systemic scleroderma, Raynaud's phenomenon

Interventions

Following a one-week of no-treatment observation period, study participants are instructed to insert the applied disposable warmers into holders antd place them on the both upper arms near the elbow f

Sponsors

Shima Yoshihito
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients attending Osaka University Hospital 2.20 years old or older and under 80 years old 3.Patients with systemic sclerosis who meet the classification criteria by the ACR/EULAR 2013 and have Raynaud's phenomenon. 4.Patients who have been fully informed of the study and who have given written consent of their own free wil.

Exclusion criteria

Exclusion criteria: 1. Patients chronically febrile due to primary disease or comorbidities 2. Patients with Diabetes mellitus 3. Patients with another skin disease except systemic sclerosis at the site of wearing the warmer 4. Patients who are incapable of taking off the warmer by themselves 5. Patients with peripheral neuropathy of upper extremities or past medical history of that 6. Patients with vascular shunt on the arm for hemodialysis 7. Patients who are judged as ineligible by the responsible researcher for other reasons

Design outcomes

Primary

MeasureTime frame
The change in the average Raynaud Condition Score (RCS) recorded in the participants' diary between the warmer-applied period and non-warmer-applied period for each of the three temperature of the warmer.

Secondary

MeasureTime frame
1. Number and frequency of Raynaud's phenomenon as recorded in the diary (times/day) 2. Total duration of Raynaud's phenomenon per day (minutes/day) 3. Number and frequency of adverse events

Contacts

Public ContactAkane Watanabe

Osaka Uversity Hospital

a.watanabe@imed3.med.osaka-u.ac.jp+81-6-6879-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026